|
顯示項目 677751-677760 / 2346288 (共234629頁)
<< < 67771 67772 67773 67774 67775 67776 67777 67778 67779 67780 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-11-23T02:23:15Z |
Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
|
Chen, Ya-Hui; Chen, Hui-Ling; CHENG-MAW HO; Chen, Hung-Yen; Ho, Shu-Li; Hu, Rey-Heng; Lee, Po-Huang; Chang, Mei-Hwei |
| 臺大學術典藏 |
2020-05-26T09:26:44Z |
Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity
|
Box M; Johnström P; Varnäs K; Malmquist J; Thress K.S; Jänne P.A; Cross D.; Cross D.;J?nne P.A;Thress K.S;Malmquist J;Varn?s K;Johnstr?m P;Box M;Grist M;Hickey M;Jordan A;Pickup K;Cantarini M;Chih-Hsin Yang;Kim D.-W;Yang Z;Yates J.W.T;Ballard P; Ballard P; Yates J.W.T; Yang Z; Kim D.-W; CHIH-HSIN YANG; Cantarini M; Pickup K; Jordan A; Hickey M; Grist M |
| 臺北醫學大學 |
2009 |
Preclinical Development of TW01001 and TW01002 as Antitumor Agents
|
王惠珀 |
| 國立臺灣大學 |
2016 |
Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis
|
Lin, Chien-Ju; Chang, Ya-An; Lin, Yi-Ling; Liu, Shing Hwa; Chang, Cheng-Kuei; Chen, Ruei-Ming; 劉興華 |
| 臺大學術典藏 |
2018-09-10T15:32:41Z |
Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis
|
Lin, C.-J.;Chang, Y.-A.;Lin, Y.-L.;Liu, S.H.;Chang, C.-K.;Chen, R.-M.; SHING-HWA LIU |
| 臺大學術典藏 |
2021-07-05T02:45:34Z |
Preclinical evaluation of a 3D-printed hydroxyapatite/poly(lactic-co-glycolic acid) scaffold for ridge augmentation
|
Chang P.-C.; Luo H.-T.; Lin Z.-J.; Tai W.-C.; Chang C.-H.; Chang Y.-C.; Cochran D.L.; MIN-HUEY CHEN |
| 臺大學術典藏 |
2021-07-08T00:54:54Z |
Preclinical evaluation of a 3D-printed hydroxyapatite/poly(lactic-co-glycolic acid) scaffold for ridge augmentation
|
PO-CHUN CHANG; Luo H.-T.; Lin Z.-J.; Tai W.-C.; Chang C.-H.; Chang Y.-C.; Cochran D.L.; Chen M.-H. |
| 國立臺灣科技大學 |
2016 |
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
|
Lin, C.-K;Bai, M.-Y;Hu, T.-M;Wang, Y.-C;Chao, T.-K;Weng, S.-J;Huang, R.-L;Su, P.-H;Lai, H.-C. |
| 中國文化大學 |
2012-05 |
Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging
|
Yeh, CT (Yeh, Chi-Tai); Rao, YK (Rao, Yerra Koteswara); Ye, M (Ye, Min); Wu, WS (Wu, Wen-Shi); Chang, TC (Chang, Tung-Chen); Wang, LS (Wang, Liang-Shun); Wu, CH (Wu, Chih-Hsiung); Wu, ATH (Wu, Alexander T.H.); Tzeng, YM (Tzeng, Yew-Min) |
| 臺北醫學大學 |
2012 |
Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging
|
Yeh, CT;Rao, YK;Ye, M;Wu, WS;Chang, TC;Wang, LS;Wu, CH;Wu, AT;Tzeng, YM |
顯示項目 677751-677760 / 2346288 (共234629頁)
<< < 67771 67772 67773 67774 67775 67776 67777 67778 67779 67780 > >>
每頁顯示[10|25|50]項目
|
